173 related articles for article (PubMed ID: 36933158)
21. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
22. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
23. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
[TBL] [Abstract][Full Text] [Related]
24. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
Zhang H; Su X; Burley SK; Zheng XFS
Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
[No Abstract] [Full Text] [Related]
25. LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma.
Tao L; Li D; Mu S; Tian G; Yan G
Lab Invest; 2022 May; 102(5):494-504. PubMed ID: 35264707
[TBL] [Abstract][Full Text] [Related]
26. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of a novel LncRNA AC104958.2 stabilized by PCBP2 promotes proliferation and microvascular invasion in hepatocellular carcinoma.
Ma Z; Li S; Wang Y; Zhang J; Zeng X
Exp Cell Res; 2021 Oct; 407(1):112791. PubMed ID: 34418457
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q
J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558
[TBL] [Abstract][Full Text] [Related]
29. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
31. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
32. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
35. Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma.
Wang X; Zhou Y; Dong K; Zhang H; Gong J; Wang S
Environ Toxicol; 2022 Jun; 37(6):1357-1372. PubMed ID: 35179300
[TBL] [Abstract][Full Text] [Related]
36. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
37. Exosomal ZFPM2-AS1 contributes to tumorigenesis, metastasis, stemness, macrophage polarization, and infiltration in hepatocellular carcinoma through PKM mediated glycolysis.
Ji W; Bai J; Ke Y
Environ Toxicol; 2023 Jun; 38(6):1332-1346. PubMed ID: 36880413
[TBL] [Abstract][Full Text] [Related]
38. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
39. LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.
Chen B; Xu X; Wu W; Zheng K; Yu Y
Anal Cell Pathol (Amst); 2023; 2023():5852963. PubMed ID: 37234237
[TBL] [Abstract][Full Text] [Related]
40. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]